Eleanor "Nora" Taranto, MD, MSCE
Assistant Professor of Medicine, University of Pennsylvania; Medical Oncologist, Abramson Cancer Center
Highlights
- Breast medical oncologist and clinician-scientist specializing in biomarker-informed targeted therapy
- Co-lead investigator of the QuantifyHER study, which seeks to improve HER2 testing and treatment selection
Eleanor “Nora” Taranto, MD, MSCE, is a breast medical oncologist at the Abramson Cancer Center at the University of Pennsylvania. She provides patient-centered, evidence-based care for individuals with breast cancer, with particular expertise in targeted therapies and treatment decisions informed by tumor testing.
Dr. Taranto’s research focuses on improving how tumor markers are measured and used to guide therapy. She is a lead investigator of the QuantifyHER study, a multi-site initiative evaluating new approaches to HER2 testing to better match patients with antibody-drug conjugate treatments. Her broader work includes studying circulating tumor DNA and other markers to better understand recurrence risk and treatment response.
She completed a Master of Science in Clinical Epidemiology to strengthen her expertise in clinical trial design and biomarker evaluation. Dr. Taranto is also engaged in medical education and science communication, serving as Editor-in-Chief of The Curbsiders Digest, where she helps translate emerging research into accessible clinical insights.